Gulasal Kuryozova

6 ta ish

Bukhara Medical Institute named after Abu Ali Ibn Sina

1. IMMUNOHISTOCHEMICAL CHARACTERISTICS OF ENDOMETRIAL TUMORS

   Gulasal Kuryozova

   MaqolaEndometrial and Cervical Cancer TreatmentsZenodo (CERN European Organization for Nuclear Research)20260 iqtibos

   ABIABI:AkademIndex/openalex/2026.article.007426

2. IMMUNOHISTOCHEMICAL CHARACTERISTICS OF ENDOMETRIAL TUMORS

   Gulasal Kuryozova

   MaqolaEndometrial and Cervical Cancer TreatmentsZenodo (CERN European Organization for Nuclear Research)20260 iqtibos

   ABIABI:AkademIndex/openalex/2026.article.007447

3. ANALYSIS OF ADVERSE PROGNOSTIC FACTORS IN ENDOMETRIAL CANCER

   Gulasal Kuryozova

   MaqolaEndometrial and Cervical Cancer TreatmentsZenodo (CERN European Organization for Nuclear Research)20260 iqtibos

   ABIABI:AkademIndex/openalex/2026.article.007615

4. ANALYSIS OF ADVERSE PROGNOSTIC FACTORS IN ENDOMETRIAL CANCER

   Gulasal Kuryozova

   MaqolaEndometrial and Cervical Cancer TreatmentsZenodo (CERN European Organization for Nuclear Research)20260 iqtibos

   ABIABI:AkademIndex/openalex/2026.article.007676

5. ANALYSIS OF ADVERSE PROGNOSTIC FACTORS IN ENDOMETRIAL CANCER

   Gulasal Kuryozova

   MaqolaEndometrial and Cervical Cancer TreatmentsZenodo (CERN European Organization for Nuclear Research)20260 iqtibos

   ABIABI:AkademIndex/openalex/2026.article.007726

6. ANALYSIS OF ADVERSE PROGNOSTIC FACTORS IN ENDOMETRIAL CANCER

   Gulasal Kuryozova

   MaqolaEndometrial and Cervical Cancer TreatmentsZenodo (CERN European Organization for Nuclear Research)20260 iqtibos

   ABIABI:AkademIndex/openalex/2026.article.007778